Related Experiment Videos
Second malignant neoplasms following hematopoietic stem cell transplantation
Debra L Friedman1, Wendy Leisenring, Jeffrey L Schwartz
1University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. debra.friedman@seattlechildrens.org
International Journal of Hematology
|June 1, 2004
Abstract:
Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research.